Sun Pharma signs Akshay Kumar as brand ambassador for Revital H

New Delhi: Sun Pharma signs Akshay Kumar as brand ambassador for Revital H Drug major Sun Pharmaceutical Industries Monday said Sun Pharma Consumer Healthcare has signed Bollywood star Akshay Kumar as the brand ambassador of health supplement Revital H.

“In Akshay Kumar, we have found a perfect ambassador who is not only physically fit but also exudes great energy at all times – attributes that define Revital H at its core,” Sun Pharma CEO – India, Emerging Markets and Consumer Healthcare Kal Sundaram said.

Shares of Sun Pharmaceutical Industries on Monday were trading at Rs 569.45 per scrip in the afternoon trade on BSE, up 1.97 per cent from its previous close.

  • Related Posts

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    Hyderabad: The collaborative landscape of international pharmaceutical oversight reached a new milestone on May 5, 2026, as the Drugs Control Administration (DCA) of Telangana hosted the Second Regulatory Forum with…

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Spiritualism n Compassion being core of his Nature, Poor Patients may Hope for Best New Delhi: ‘Nishant’ literally meaning daybreak, Bihar may well hope to see a new Dawn of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Six Women Develop Serious Complications After C-Section

    Six Women Develop Serious Complications After C-Section

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

    Indian Pharma Majors Plan to Invest in US

    Indian Pharma Majors Plan to Invest in US

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr